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Autophagy-mediated antigen processing in CD4(+) T cell
tolerance and immunity
Abstract
Macroautophagy, a homeostatic process that shuttles cytoplasmic constituents into endosomal and
lysosomal compartments, has recently been shown to deliver antigens for presentation on major
histocompatibility complex (MHC) class II. Autophagy-mediated antigen processing in thymic
epithelial cells has been suggested to be involved in the generation of a self-MHC restricted and
self-tolerant CD4(+) T cell repertoire. Furthermore, there is accumulating evidence that the
up-regulation of autophagy by pattern-recognition receptor signaling represents an innate defense
mechanism against intracellular pathogens. Thus, through linking pathogen breakdown with the
presentation of pathogen-derived autophagy substrates on MHC class II, autophagy serves a dual
function at the interface of the innate and the adaptive immune response.
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Summary 
 
Lysosomal degradation products are displayed by major histocompatibility 
class (MHC) II molecules to CD4+ T cells to mount adaptive immune responses. 
Autophagy is a homeostatic process by which cells deliver cytoplasmic constituents 
to late endosomal and lysosomal compartments. Studies in cell culture systems, 
including antigen presentation assays, co-localization studies and sequencing of 
MHC class II bound peptides, demonstrated that both self- and pathogen-derived 
substrates of autophagy can be loaded onto MHC class II for CD4+ T cell recognition. 
The first in vivo situation that was identified to require autophagy-mediated antigen 
processing for MHC class II presentation is thymic T cell selection for the induction of 
immunological tolerance. Mature T cell that exit the thymus monitor autophagy 
substrates for evidence of pathogen invasion and cellular transformation. This review 
describes the mechanisms by which the immune system utilizes autophagy to 
regulate CD4+ T cell responses during tolerance induction and in response to 
infection with intracellular pathogens.  
 
 
 
 
 
Introduction 
Autophagy is a homeostatic process by which cells recycle nutrients and 
degrade cytoplasmic constituents such as defective organelles and macromolecular 
aggregates for lysosomal degradation. There are at least three distinct pathways of 
autophagy: microautophagy, chaperone-mediated autophagy (CMA) and 
macroautophagy. Microautophagy is characterized by the uptake of cytoplasmic 
components at the lysosomal membrane via budding into the lysosome, through a 
poorly defined mechanism. Substrates for CMA carry signal peptides for sorting into 
lysosomes, similar to other protein transport mechanisms across membranes, and 
are directly imported into lysosomes through the LAMP-2a transporter [1] [2], 
assisted by cytosolic and lysosomal HSC70 chaperones. Macroautophagy is the 
major route of degradation of cytoplasmic constituents. During macroautophagy, 
cytosolic constituents including organelles are enclosed in a double-membrane 
vesicle, called autophagosome [3] [4], which then fuses with late 
endosomal/lysosomal organelles for degradation of the inner autophagosomal 
membrane and its cargo. The resulting breakdown products of macromolecules are 
subsequently released back into the cytosol through permeases in the lysosomal 
membrane, where they can be reused for anabolic or catabolic reactions [5]. 
Studies on the molecular mechanisms of macroautophagy and its importance 
in protein metabolism [5] have set the stage to analyze its role in multiple biological 
processes including innate and adaptive immune responses. In keeping with its 
cellular clearance function, macroautophagy participates in limiting pathogen 
replication in host cells. In addition, macroautphagy delivers viral, parasitic, and 
bacterial antigens to late endosomal compartments, where macroautophagy 
substrates are then degraded by lysosomal hydrolases. The fusion vesicles between 
autophagosomes and late endosomes, the so-called amphisomes, display a 
multivesicular and multilamellar morphology reminiscent of MHC class II containing 
compartments (MIICs) [6]. Indeed, studies in cell culture systems, including antigen 
presentation assays, co-localization studies and sequencing of MHC class II bound 
peptides, demonstrated that substrates of autophagy can be loaded onto MHC class 
II for CD4+ T cell recognition. The development of animal models to monitor or 
genetically disrupt macroautophagy now provide the basis for elucidating the 
immunological relevance of autophagy in vivo.  
As this review focuses on the role of autophagy in mediating CD4+ T-cell 
responses and in regulating CD4+ T-cell immunity through processing and 
presentation of intracellular antigens on MHC class II molecules, we will briefly 
outline principles of antigen processing for MHC presentation. 
	  Antigen processing and presentation 
T and B cells both express highly diverse receptors for antigen whose 
enormous variability is established through somatic rearrangement of gene 
fragments during early development of the respective lineage. Despite this similarity 
in the genetic makeup of the T and B cell receptor, there is a fundamental difference 
in how these two classes of lymphocytes recognize antigen: B cells directly recognize 
antigens through interaction of their receptor with free antigens or epitopes on the 
surface of supramolecular structures (e.g. cells, bacteria, viruses), whereby these 
epitopes can be made up of carbohydrates, lipids, proteins and even anorganic 
compounds. By contrast, T cells primarily recognize relatively small peptides that are 
generated by proteolytic breakdown of protein substrates. These peptide snippets 
are not recognized in free form, but have to be embedded in Major Histocompatibility 
Complex (MHC) molecules on the surface of cells. 
MHC molecules come in two flavors, MHC class I and MHC class II. Both 
classes of molecules share as a characteristic feature of their tertiary structure a so 
called peptide binding groove, which consists of two alpha helices outlining the rims 
of the peptide-binding moiety and a beta sheet that forms the bottom of the groove. 
Despite the overall very similar structure of MHC class I and II molecules, the details 
of their tissue distribution, physiological function and how the peptides they present 
to T cells are generated, are remarkably distinct. MHC class I is expressed on 
essentially all tissues, whereas constitutive expression of MHC class II is restricted to 
so-called professional APCs of hematopoietic origin and epithelial cells of the 
thymus. Only upon exposition to interferon-γ (IFNγ), tissues other than these will up-
regulate MHC class II expression. Whereas peptide / MHC class I (pMHCI) 
complexes represent the ligands for the TCR of CD8+ cytotoxic T cells, pMHCII 
ligands are recognized by CD4+ helper T cells. This dichotomy in the recognition of 
pMHCI or II ligands by either cytotoxic or helper T cells, respectively, reflects the 
process of positive selection during T cell development in the thymus. This rather 
wasteful process ensures that immature T cells commit to the CD8+ or CD4+ lineage 
according to the principal capacity of their randomly rearranged TCR for MHC class I 
or II, respectively. As a result, cytotoxic T cells express the CD8 co-receptor, 
whereas helper T cells express the CD4 co-receptor, which interact with non-
polymorphic regions of MHC class I or II, respectively. 
The basic principles of how peptides embedded in MHC class I or II are 
generated have been well established over the last two decades. Thus, MHC class II 
bound epitopes are primarily generated through the proteolytic processing of proteins 
that reach endosomal/lysosomal compartments subsequent to having been taken up 
from the extracellular space. By contrast, MHC class I bound peptides are mostly 
derived from proteasomal substates, that is, mis-folded cytoplasmic proteins that 
have been earmarked for degradation by ubiquitination. 
At first glance, the paradigm that MHC class I or MHC class II bound peptides 
originate from topologically distinct sources represents an elegant way how the 
immune system copes with the challenge that the eradication of intra- or extracellular 
pathogens necessitates fundamentally different effector mechanisms. Thus, the 
control of viral infections requires that those cells that have been infected are 
eliminated by MHC class I-restricted CD8+ cytotoxic T cells. By contrast, the 
clearance of extracellular pathogens such as most bacteria or helminths is largely 
dependent on antibody responses. In this case, MHC class II-restricted CD4+ helper 
T cells fulfill a critical pacemaker function for humoral immune responses in the form 
of cytokines that orchestrate the efficient production of antibodies by B cells. 
A closer look, however, renders an absolutely strict topological demarcation of 
the origin of MHC class I and MHC class II bound peptides epitopes rather unlikely. 
For example, the initiation of certain antiviral cytotoxic CD8+ T cell responses is 
dependent on the MHC class I-restricted presentation of viral epitopes by dendritic 
cells (DCs), the major type of so-called “professional antigen presenting cells 
(APCs)”. Paradoxically, however, many viruses do not infect DCs, and yet elicit 
strong cytotoxic T cell responses. This observation underscores the physiological 
relevance of an “unconventional” MHC I loading pathway that involves the shuttling of 
exogenous material, in this case viral proteins, into the MHC class I loading pathway 
of DCs, a process termed cross-presentation. Vice versa, early evidence for 
exceptions from the “rule” that MHC class II molecules are exclusively occupied by 
peptides of extracellular origin was provided by the sequencing of peptides eluted 
from MHC class II, revealing that around 20 % of the identified epitopes originated 
from intracellular sources such as mitochondrial proteins, cytoskeletal proteins, 
metabolic enzymes, chaperones and nuclear proteins. 
How do epitopes derived from cytoplasmic proteins gain access to MHC class 
II molecules? The candidate pathways implicated in so-called “endogenous MHC 
class II loading” can be grouped into two groups, depending on whether the 
intersection with the conventional exogenous MHC class II loading pathway occurs 
upstream or downstream of the proteolytic degradation of the substrate. The first 
category involves proteasomal antigen processing and subsequent TAP-mediated 
import of degradation products into the ER and thus may be best described as “spill-
over” from the MHC class I pathway into MHC class II loading compartments. The 
second category encompasses a rather heterogeneous group of mechanisms that 
deliver cytoplasmic material for lysosomal degradation, including chaperone 
mediated autophagy and macroautophagy. We will primarily focus on 
macroautophagy in this review, because this pathway was frequently suggested to 
deliver cytoplasmic material for MHC class II loading.   
 
Autophagy substrates are loaded onto MHC class II molecules 
More than a decade ago, the lab of Gitta Stockinger reported that treatment of 
macrophages and B cells with the autophagy inhibitor 3-methyl adenine (3-MA) 
prevented the presentation of an endogenously synthesized protein on MHC class II 
[7]. On this basis, these authors suggested that macroautophagy may shuttle 
cytosolic proteins into MHC class II loading compartments. In a subsequent study, 
Mautner and colleagues found that transfection of a renal carcinoma cell line with a 
model antigen resulted in the endogenous processing for MHC class II restricted 
presentation to CD4 T cells, and again, this process could be inhibited by 3-MA [8]. A 
caveat of both studies was that they involved the ectopic over-expression of the 
respective model antigens. The first study to document a role for macroautophagy in 
loading of a physiologically expressed cytoplasmic antigen dealt with the recognition 
of the nuclear antigen 1 (EBNA1) of Epstein Barr virus by CD4+ T cells. It was found 
that EBNA1 gains access to MHC class II in EBV transformed B cells [9], and that 
EBNA1 was detectable in autophagosomes when lysosomal proteolysis was inhibited 
[9]. Inhibition of macroautophagy by 3-MA or RNA interference directed against 
Atg12 strongly diminished recognition of these cell lines by EBNA 1 specific CD4+ T 
cells [9]. In further support of a role for macroautophagy in endogenous MHC class II 
loading, recognition of tumor antigen derived epitopes on MHC class II after RNA 
transfection of dendritic cells was reduced by 3-MA [10]. In support of a broader 
relevance of endogenous MHC class II loading, it could be demonstrated that 
macroautophagy is constitutively (i.e. even under nutrient rich conditions) active at a 
relatively low but detectable level in a variety of MHC class II positive APCs such as 
dendritic cells, B cells and monocytes. Co-localization studies indicated that in these 
cell types, autophagosomes indeed frequently fuse with MHC class II-loading 
compartments, and deliberate experimental delivery of a viral antigen to 
autophagosomes by targeting to the autophagosomal membrane through fusion with 
Atg8/LC3, a ubiquitin-like protein that gets covalently attached to the autophagic 
membrane during macroautophagy, resulted in robust recognition by specific CD4+ T 
cells [11]. The most direct evidence for delivery of autophagy substrates to the MHC 
class II pathway was obtained by eluting and sequencing MHC II bound epitopes 
before and after switching to nutrient deprived conditions, indicating that starvation 
induction of macroautophagy resulted in a higher prevalence of cytoplasm- or 
organelle-derived peptides [12]. These studies demonstrated that macroautophagy 
can deliver substrates for MHC class II presentation. 
         
Autophagy in thymic epithelial cells mediates CD4+ T cell tolerance  
The first in vivo situation that was identified to require macroautophagy 
mediated antigen processing for MHC class II presentation is T cell selection. The 
composition and specificity of the TCR result from random somatic rearrangement of 
gene segments at an early intrathymic developmental stage. Inevitably, the 
stochastic nature of this process leads to the emergence of T cells that carry 
receptors that are either “useless” or “harmful”: the former because they may not 
confer the capacity to interact with self-MHC molecules at all, and the latter because 
they may possess a specificity for self-antigens and hence be potentially dangerous. 
In order to remove such specificities from the T cell pool, the nascent T cell repertoire 
is subject to positive and negative selection. For the sake of conceptual clarity, it may 
in the context of this discussion be helpful to think of these two processes as being 
spatially and temporally segregated (although this is an issue of long-standing 
controversy). Thus, immature thymocytes first “test” the capacity of their TCR to 
engage pMHC class I and pMHC class II ligands presented by cortical thymic 
epithelial cells (cTECs), and T cell survival (“positive selection”) at this stage is 
contingent upon low affinity interactions (reference). Furthermore, it is also on the 
basis of interactions with pMHC ligands on cTECs that thymocytes commit to the 
CD4+ or CD8+ lineage according to the capacity of their TCR to interact with MHC 
class II or MHC class I, respectively. Remarkably, about 80-90% of thymocytes fail to 
fulfill the criteria for positive selection and die “by default”. Subsequent to positive 
selection, thymocytes translocate to medullary regions of the thymus where their 
TCRs are tested for overt self-reactivity with pMHC ligands on different subsets of 
dendritic cells as well as medullary thymic epithelial cells (mTECs). Here, T cells that 
interact strongly with pMHC ligands on APCs in the medulla are subject to negative 
selection (also known as “clonal deletion”). 
The essential or at least significant role of cTECs and mTECs for positive 
selection or tolerance induction, respectively, provides an obvious explanation for 
why these two developmentally related thymic stromal cell subsets are the only non-
hematopoietic cell types that constitutively express MHC class II molecules. 
Remarkably, both cTECs and mTECs were found to be extremely inefficient in 
delivering epitopes derived from exogenous antigens onto MHC class II, a feature 
that clearly distinguishes them from thymic DCs (reference). On this basis, it was 
suggested that they may predominantly present endogenously derived peptides on 
MHC class II (reference), and the discovery in LC3-GFP transgenic, macroautophagy 
reporter mice that thymic epithelial cells, and foremost cTECs, display an unusually 
high rate of starvation independent, constitutive macroautophagy provided an 
intriguing piece of evidence in favor of this idea [13]. More recently, it has been 
reported that in both cortical and medullary TEC lines, LC3 was colocalized with 
markers for MHC class II loading compartments [14]. These results strongly suggest 
that cytoplasmic self antigens expressed in the thymus gain access to MHC class II 
loading via autophagy. 
The hypothesis that macroautophagy in cTECs contributes to the generation 
of pMHC class II ligands for positive selection was addressed using the autophagy 
deficient Atg5–/– mouse mutant [15]. The neonatal lethality of Atg5–/– mice, at least in 
part caused by impaired bridging of a metabolic crisis related to the transition from 
trans-placental to milk-derived nutrient supplies, precluded a straight-forward 
assessment of T cell development in this system. To circumvent this complication, 
embryonic thymi were transplanted under the kidney capsule of wild-type recipients, 
a well established procedure to study the effects of a particular genetic lesion 
specifically in thymic epithelial cells (In these grafts, hematopoietic cells, i.e. T cells 
and dendritic cells, turn-over and are eventually replaced by host-type cells, whereas 
both cTECs and mTECs are replenished from a precursor pool of donor origin). It 
turned out that positive selection of a number of MHC class II-restricted TCR 
specificities was affected in the absence of autophagy in thymic epithelium [16]. Of 
note, depending on the TCR tested, the alterations in the efficacy of positive 
selection could be either of detrimental or beneficial nature, strongly supporting the 
view that the general capacity of cTECs to support positive selection was not 
impaired. Thus, the most likely explanation for the effects of abrogated epithelial 
macroautophagy on positive selection is that certain peptides that normally foster the 
positive selection of particular TCR specificities may not or only inefficiently be 
generated, while other, “macroautophagy-independent” ligands may be over-
represented under these circumstances. 
A similar experimental set-up was also used to address whether the polyclonal 
T cell repertoire generated in the absence of autophagy in thymic epithelial cells was 
self-tolerant. Here, athymic nude mice (that due to a mutation in the Foxn1 
transcription factor lack fully differentiated thymic epithelial cells and consequently 
also a T cell system) were grafted with Atg5–/– or wild-type embryonic thymi. In such 
chimeras, the graft is colonized by hematopoietic precursors and within about four 
weeks, the peripheral lymphoid organs of these animals are seeded with a T cell 
repertoire that has been “educated” by pMHC ligands on autophagy deficient thymic 
epithelial cells. Quite dramatically, many chimeras carrying an Atg5–/– graft exhibited 
a substantial weight loss starting from about five weeks after grafting. Histological 
evidence and secondary transfers of peripheral T cells from diseased animals 
confirmed that these symptoms were caused by immune mediated tissue-damage. 
In sum, the function of constitutive macroautophagy in thymic epithelial cells 
may therefore be two-fold. First, autophagy may generate endogenously derived 
MHC class II-bound peptides on cTECs for positive selection of CD4+ T cells. 
Second, it is conceivable that macroautophagy similarly shuttles cytoplasmic or 
organelle-derived self-antigens into the MHC class II-loading pathway of mTECs, in 
this case for tolerance induction within the nascent CD4+ T cell repertoire. This latter 
scenario might be of particular significance considering that mTECs broaden the 
scope of self-antigens available for central tolerance induction by ectopically 
expressing a wide array of otherwise strictly tissue-specific self antigens. 
    
Harnessing autophagy to enhance CD4+ T cell immunity 
In addition to its role in thymic T cell selection, MHC class II loading after 
macroautophagy probably also contributes to the priming of CD4+ T cell responses 
during vaccination and infection. Especially pathogens that are restricted by 
macroautophagy could give rise to MHC class II ligands after their degradation via 
this catabolic pathway. Along these lines, bacteria and parasites that either escape 
endosomes for replication in the cytosol or condition their phagosome to prevent 
fusion with lysosomes, but instead serve as their replication niche, have been found 
to be delivered for lysosomal degradation via macroautophagy. Among these 
pathogens are group A Streptococci, Listeria monocytogenes and Shigella flexnerii, 
which replicate in the cytosol after breaching the endosomal membrane during 
uptake and can be engulfed by autophagosomes [17] [18] [19]. This innate restriction 
of cytosolic bacteria seems to have forced successful pathogens to evolve evasion 
mechanisms. Thus, Listeria decreases engulfment into autophagosomes by 
surrounding itself with coats of cellular components. It induces an actin coat by ActA, 
independent of the contribution of this protein to bacterial mobility [19], or by hiding in 
incompletely listeriolysin O-permeabilized endosomes [20].  Furthermore, the VirA 
protein of Shigella, another protein involved in bacterial actin-based mobility, is 
recognized by the molecular macroautophagy machinery and this can lead to 
selective engulfment of these bacteria by autophagosomes [18]. However, Shigella 
carries the IcsB protein that blocks VirA recognition, resulting in bacterial evasion 
from macroautophagy. Alternatively, pathogens that condition their phagosomes after 
endocytic uptake, like Mycobacterium tuberculosis or Toxoplasma gondii, can be 
targeted for lysosomal degradation via stimulation of macroautophagy [21] [22] [23] 
[24] [25]. These conditioned phagosomes might be delivered to lysosomes via fusion 
with autophagosomes or engulfment by these vesicles. Interestingly, 
macroautophagic clearance of these pathogen-conditioned phagosomes requires 
immunity-related p47 GTPases, like immunity-related GTPase M (IRGM) and a6 
(Irga6) [26] [22] [24] [27] [28]. The recruitment of these to the bacterial phagosome 
enhances fusion with lysosomes and clearance of the pathogens. This innate 
restriction of intracellular pathogens is co-opted by the immune system for CD4+ T 
cell priming. Accordingly, MHC class II presentation of the antigen Ag85B of 
Mycobacterium tuberculosis can be enhanced by macroautophagy stimulation via 
mTOR blocking with rapamycin [29]. DCs with macroautophagy-enhanced MHC 
class II presentation of Ag85B induced 2-6fold higher CD4+ T cell responses after 
vaccination through adoptive transfer into mice. In addition, mycobacteria 
overexpressing Ag85B and the presentation of this antigen on MHC class II 
molecules after macroautophagy elicited protective CD4+ T cell responses, which 
controlled pathogen titers in the lung at 1log lower set-points. These findings suggest 
that intracellular pathogen degradation, which serves the purpose of restricting 
bacteria and parasites during innate immune responses, leads also to antigen 
presentation on MHC class II molecules for the induction of protective CD4+ T cell 
responses. This enhanced MHC class II presentation after macroautophagy induction 
can also be harnessed to increase vaccine efficacy, as shown for immunization by 
adoptive transfer of DCs with enhanced mycobacterial antigen presentation on MHC 
class II after macroautophagy stimulation. 
 
Immune signals regulate autophagic activity 
The ability of the host to defend against invading pathogens is largely 
mediated by a group of germline-encoded receptors known as pattern-recognition 
receptors (PRRs). These molecules include Toll-like receptors (TLRs), nucleotide-
binding and oligomerization domain (NOD)-like receptors (NLRs), retinoic-acid-
inducible gene I (RIG-I)-like helicases (RLRs) and a subset of C-type lectin receptors 
(CLRs), which together recognize a large number of molecular patterns in bacteria, 
viruses and fungi. The signaling pathways that are triggered by PRR ligation through 
pathogen associated molecular patterns (PAMPs) lead to cellular activation, which 
increases the antigen-presenting capacity and the expression of co-stimulatory 
molecules APCs, as well as their production of type I interferons, pro-inflammatory 
cytokines and chemokines, which initiate and direct the immune response against the 
invading pathogen. Macroautophagy assists PRRs in meeting their cognate ligands 
and represents an immune effector mechanism downstream of PRR stimulation. For 
example, intracellular replication intermediates of vesicular stomatitis virus (VSV), 
recognized by PRRs, are delivered to endosomally located TLR7 which results in 
robust type I interferon-dependent innate immune respones by plasmacytoid 
dendritic cells (pDCs) [30]. As an effector mechanism, PRR signaling can induce or 
augment macroautophagy [31] [32]. Intracellular PRR rather than receptors that 
survey the extracellular envirnonment are key candidates for linking pathogen 
sensing with macroautophagy induction. Cells from Drosophila melanogaster rely on 
intracellular peptidoglycan-sensing molecules to trigger autophagy following Listeria 
monocytogenes infection.  Indeed, this autophagy response appears to be required 
fort the control of L. monocytogenes infection and survival of the host [33]. Likewise, 
the intracellular PRRs Nod1 and Nod2, which sense peptidoglycan moieties released 
from the bacterial cell walls, can act as nucleation sites for autophagy initiation 
following bacterial infection [34]. In the latter study, Nod1 and Nod2 recruited the 
autophay protein ATG16L1 to the plasma membrane at the bacterial entry site, 
whereas function-altering Nod2 mutations lead to impaired wrapping of invading 
bacteria by autophagosomes [34]. Thus, macroautophagy does not only target 
PAMPs to endosomal PRRs for immune recognition, but is also susceptible to PRR 
stimulation suggesting that the PRR signaling pathway could be exploited for the 
elimination of intracellular pathogens through induction of macroautophagy. 
In addition to PRR signaling, cytokines such as interferons (IFNs) and 
members of the tumor necrosis factor (TNF) receptor ligand family such as CD40-
CD40L stimulation are capable of modulating macroautophagy in susceptible cells. 
Restriction of HSV-1 infection by macroautophagy in vitro and in vivo was found to be 
dependent on type I IFN signaling [35]. IFN-gamma has been reported to enhance M. 
tuberculosis and Ricksettia conorii degradation by macroautophagy in infected cells 
[21] [22]. IFN-gamma induces macroautophagy and mycobacterial clearance through 
the function of immunity-related GTPases (IRGs) [36]. In contrast, Th2 signature 
cytokines such as interleukin (IL)-4 and IL-13 appear to inhibit IFN-gamma induced 
autophagic delivery of mycobactria into degradative compartments [37]. It is, 
however, important to note that mouse tissues are probably more susceptible to IFN-
gamma-mediated macroautophagy regulation because their IRGs are IFN-gamma 
inducible, whereas the human IRG is not, suggesting that immune signals that 
stimulate macroautophagy differ between rodents and man.  
TNF-alpha was found to upregulate macroautophagy in cells lacking NF-kB 
activation [38] and TNF-related apoptosis-inducing ligand (TRAIL) was described to 
induce macroautophagy in the human epithelial cells  [39]. Consistent with this, 
inactivation of Fas-associated death domain (FADD), the signaling adapter protein of 
the TRAIL receptor, decreases macroautophagy induction by TRAIL [40]. As a third 
TNF family member, CD40L has been demonstrated to induce macroautophagy-
mediated fusion of Toxoplasma gondii-containing phagosomes with lysosomes 
through CD40 signaling on mouse and human macrophages [23].  These data 
suggest that autophagy does not only regulate CD4+ T cell responses through 
endogenous antigen presentation but that autophagic activity is also regulated by 
inflammatory mediators. Immune-mediated macroautopagy regulation via cytokines 
or membrane-bound molecules could represent feedback mechanisms by which 
activated T cells augment macroautophagy during immune activation.  
 
 
Conclusions and Outlook 
Both innate and adaptive immune responses use autophagy for intracellular 
clearance of pathogens as well as for presentation of pathogen fragments to the 
adaptive immune system. Since the same mechanisms are used for the steady-state 
turnover of cellular self-components, the immune system has to be desensitized not 
to recognize these. Macroautophagy in thymic epithelial cells contributes to CD4+ T 
cell selection and is essential for the generation of a self-tolerant T cell repertoire. 
However, some autoreactive lymhocytes escape central tolerance induction, exit the 
thymus and enter the periphery as mature T cells. These circulating autoantigen-
specific T cells are thought to play a key role in the initiation and perpetuation of 
many autoimmune diseases [41]. Peripheral mechanisms of self tolerance include 
deletion or abortive activation of autoreactive lymphocytes by autoantigen-specific 
APCs that express low levels of costimulators. It is currently not know whether 
macroautophagy, in addition to its function in thymic T cell selection, is involved in 
peripheral tolerance maintenance in the CD4+ T cell compartment. 
Recent studies also suggessted a role for macroautophagy in regulating 
intracellular antigen processing for MHC class I presentation and in packaging 
antigens for optimal crosspresentation on MHC class I molecules [42] [43]. While 
these additional pathways require further investigation to understand the underlying 
mechanisms, autophagy-mediated antigen delivery to both MHC class II and MHC 
class I molecules should be explored for its potential to increase the efficacy of 
vaccination strategies, to enhance adaptive immune responses during chronic 
infections or to limit inflammatory tissue damage in T cell-driven autoimmune 
diseases. Future studies might provide a more precise understanding of how and by 
which mechanisms autophagy regulates T cell immunity and tolerance during health 
and disease in vivo and how this pathway could be harnessed for vaccination and 
immunotherapy. 
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Figures 
 
Figure 1. Macroautophagy in MHC class II antigen processing. Antigens for MHC 
class I presentation are derived from proteins that are degraded in the cytosol by the 
proteasome. With the help of the MHC class I loading complex, individual peptides of 
8–9 amino acids in length are loaded into the peptide-binding groove of MHC class I 
molecules. Stable peptide–MHC class I complexes are then exported through the 
Golgi apparatus to the cell surface for recognition by CD8+ T cells. MHC class II 
molecules bind peptides generated in the endosomal-lysosomal systems and display 
them on the cell surface for recognition of CD4+ T cells. Extracellular antigens are 
taken up via endocytosis/phagocytosis into endosomal compartments and are 
degraded by lysosomal proteases before they gain access to late endosomal MHC 
class II-loading compartments (MIICs). Like classical MHC class I molecules, newly 
synthesized MHC class II molecules are unstable in the absence of bound peptide. 
Therefore, the transmembrane protein invariant chain (Ii) protein (shown in purple) 
blocks the peptide-binding groove MHC class II molecules after their synthesis in the 
ER to prevent premature binding of antigens. MHC class II-li complexes move 
through the Golgi to MIICs, where lysosomal proteases also degrade the Ii, and the 
remaining peptide (CLIP for class II-associated Ii peptide) is exchanged for antigenic 
peptides with the help of the non-classical MHC class II molecule HLA-DM. High-
affinity peptide ligands bound to MHC class II molecules are then transported to the 
cell surface for CD4+ T cell immune surveillance. MHC class II ligands can reach the 
MIICs by endocytosis following lysosomal proteolysis. However, there is now 
compelling evidence that a substantial proportion of MHC class II ligands is also 
derived from intracellular source proteins and that autophagic pathways contribute to 
the delivery of these to the MIICs. During macroautophagy, the major route of 
degradation of intracellular constituents, cytoplasmic and nuclear antigens are 
enclosed in a double-membrane vesicle, called autophagosome, which then fuses 
with lysosomes and late endosomes to form multivesicular and multilamellar 
compartments, called amphisomes, in which autophagy substrates are degraded and 
loaded on MHC class II molecules. 
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